These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 123966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Proteases during the growth of Ehrlich ascites tumor. II. The kallikrein-kinin system.
    LeBlanc PP, Back N.
    J Natl Cancer Inst; 1975 May; 54(5):1107-4. PubMed ID: 236396
    [Abstract] [Full Text] [Related]

  • 4. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
    Donenko FV, Kabieva AO, Moroz LV.
    Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
    [Abstract] [Full Text] [Related]

  • 5. Production of interferon and other lymphokines during murine tumour growth. II. Induction of an interferon by Ehrlich ascites cells in outbred mice.
    Lackovic V, Borecký L, Zschiesche W, Fahlbusch B, Schumann I.
    Acta Virol; 1980 Jan; 24(1):45-54. PubMed ID: 6155777
    [Abstract] [Full Text] [Related]

  • 6. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV, Kabieva AO, Moroz LV.
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Blood ammonia in mice bearing Ehrlich ascites tumors].
    Carrascosa JM, Martínez P, Núñez de Castro I.
    Rev Esp Fisiol; 1982 Jul; 38 Suppl():195-8. PubMed ID: 7146577
    [Abstract] [Full Text] [Related]

  • 9. Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.
    van Hensbergen Y, Broxterman HJ, Hanemaaijer R, Jorna AS, van Lent NA, Verheul HM, Pinedo HM, Hoekman K.
    Clin Cancer Res; 2002 Dec; 8(12):3747-54. PubMed ID: 12473585
    [Abstract] [Full Text] [Related]

  • 10. A factor responsible for increases in ornithine decarboxylase activity in the livers of tumor-bearing mice.
    Noguchi T, Kashiwagi A, Tanaka T.
    Cancer Res; 1976 Nov; 36(11 Pt 1):4015-22. PubMed ID: 975047
    [Abstract] [Full Text] [Related]

  • 11. Proteases in human tumors.
    Burtin P, Chavanel G, Fondaneche MC.
    Bull Cancer; 1984 Nov; 71(5):474-80. PubMed ID: 6240998
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW.
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Action of brinase on human fibrinogen and plasminogen.
    Vanhove P, Donati MB, Claeys H, Verhaeghe R, Vermylen J.
    Thromb Haemost; 1979 Aug 31; 42(2):571-81. PubMed ID: 159511
    [Abstract] [Full Text] [Related]

  • 16. Metabolic activity of the Ehrlich ascites carcinoma cells and the significance of ascites serum addition.
    Miko M, Drobnica L.
    Neoplasma; 1969 Aug 31; 16(2):161-9. PubMed ID: 5822918
    [No Abstract] [Full Text] [Related]

  • 17. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A, Hristescu S, Mazilu E.
    Neoplasma; 1983 Aug 31; 30(2):147-52. PubMed ID: 6843720
    [Abstract] [Full Text] [Related]

  • 18. [The kinetics of changes in sulfhydryl and disulfide groups and proteins during growth of Ehrlich ascites tumor].
    Romanovskii IV, Agatova AI, Novikova EN.
    Vopr Onkol; 1973 Aug 31; 19(6):60-4. PubMed ID: 4778562
    [No Abstract] [Full Text] [Related]

  • 19. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
    Rość D, Powierza W, Zastawna E, Drewniak W, Michalski A, Kotschy M.
    Med Sci Monit; 2002 May 31; 8(5):CR371-8. PubMed ID: 12011780
    [Abstract] [Full Text] [Related]

  • 20. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
    Hare TR, Gardell SJ.
    Thromb Haemost; 1992 Aug 03; 68(2):165-9. PubMed ID: 1412162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.